Protokoly_diagnostiki_i_lechenia_zabolevany
.pdf
|
|
" |
|
|
: 04-040 |
|
|
||
"$ &: " |
|
|
||
: |
|
|
|
|
& ! : |
|
|
|
|
1. |
& . |
|
|
|
2. J @+, # , , 3 |
||||
, " & & , . |
|
|
||
' & & |
: 21 & |
|
|
|
(: J18 " |
|
|
||
J15.6 |
|
, 3 & |
||
|
|
|
||
J14 , Haemophilus influenzae ( " ? &- |
||||
) |
|
|
||
J15 < & , |
||||
J13 , Streptococcus pneumoniae |
|
|
||
J15.0 |
, Klebsiella pneumoniae |
|
|
|
J15.9 |
< & " |
|
|
|
J21 |
|
|
||
J15.1 |
, Pseudomonas ( " ) |
|
||
J22 % & |
" |
|||
J15.2 |
, |
|
|
|
J15.4 |
, |
|
|
|
J15.5 |
, Escherichia coli |
|
|
|
J15.7 |
, Mycoplasma pneumonia |
|
|
|
J15.8 |
@ & |
|
|
|
J16.0 |
, |
|
|
|
J17.2* |
|
|
||
J18.1 |
@ " |
|
|
|
) : " - - & |
|
|||
, " |
$# & |
" |
|
|
% , , , & " & " % " "-& .
$ :
1.$: & " , & " , ( % ), & , , 3
2.: " , "-, , , &
3."$: , %
4.% : % , % " & %
5.% : & " & I-III, " ( , , , , ) " ( , , !!+, @'!,
+), .
* :
1.&;
2.% ;
3.;
4.& ;
5.$# – & , ,, % ;
6.( 3 );
7.;
8.&-3 " ;
9." ;
10..
" : 3 , |
|
" |
: |
: % % ( 10-12 &); 7 :
1.;
2.& " % % " " # ;
3.% (
, # % "&);
4.% ( & , , ,5 );
5.;
6.& ;
7.( II-IV);
8.2 .
5 :
1. " $, % & " . % ( &
, |
3 , |
, |
, |
& |
, |
& |
); |
|
|
|
|
2., & – " ;
3.# (6 );
4.# " ;
5.7 ;
6./ .
:
1.&;
2." # : 2 > 60 ;
2 .-12 > 50 ;12 5 > 40 ;5 28 ;
3.% % " ;
4.;
5.# ( );
6.& ( & , , , ).
" & :
1.# (6 );
2.# " ;
3./ .
7.*? + 625 , ; 600 , V;
8.*! & 100 / 3 &; 2 , 4 .; 20 ;
9. */ 250 , 500 , 1000 V;
10.*/ 250-500 , ., 125 , 250 /5 ;
11.*/ 250 , 500 .; 750 , V;
12.* 40 / , 80 /2 .
" & & :
1.500 , .;
2.! " 5 / ;
3.? 200, 800 , .;
4.*! & + 480 /5 , .; 120 , 480 , .;
5._ 480 /5 , ; 500 , .;
6.*B & 150 – 10 \ .
7. *? < 50 V ;
8.*G 250 , .; 500 , .; 1000V ;
9./ 500 , .;
/ , & :
1.Guidelines for Preventing Health-Care–Associated Pneumonia, 2003, Recommendations of CDC and the Healthcare Infection, Control Practices Advisory Committee, Morbidity and Mortality Weekly Report Recommendations and Reports March 26, 2004 / Vol. 53 / No. RR-3
2.Evidence Based Clinical Practice Guideline For Infection Prophylaxis - PCP Guideline 15, Health Policy & Clinical Effectiveness, Evidence Based Clinical Practice Guideline, Pneumocystis Carinii Pneumonia Prophylaxis following Solid Organ or Blood & Marrow Transplants Publication Date: 01-12-01
3.Pneumococcal conjugate vaccines for preventing invasive pneumococcal disease and pneumonia in children under two years of age, Evidence Summaries, 17.1.2005
4.Pneumonia, EBM Guidelines, 11.6.2004
5.Treatment of pneumonia in children, EBM Guidelines, 03.05.2000
6.' & % .
. ' ), 6) , 2003
7.@ & . >% " . ' 3. 6 , 6 ! , 2004.
8." $# " , &: ./ . M.J. K " , B.+. @ , '.B. , .6. G .- 2- ., . – 6.: 7 ;? -6>@, 2003. – 1248 .
* – , # (% % )
" &
: 05-050%
"$ &: " :
& ! :
, & "- , & , " ,.
' & & ( ): 20
(:
G24 @
I34.1 ( ) &
) : & – " ( )& % " , % - & , "$ &$ -" # " / " .
$ :
1." ;
2." (@!;, @)!;, , ' !, , '!@).H)B :
:
1 |
- |
4-6 ; |
2 |
– |
6-10 ; |
3 – |
10 . |
|
:
1.;
2.1,2,3 .
:
0, I, II?, II<, III.
* :
1.% &;
2.;
3.@!;!;
4. |
6 - ; |
5. |
'!@, 3 . |
" : .
" :
1.+ 1-2-3 ;
2.;
3.& ;
4. |
" |
% & ; |
5. |
|
. |
5 |
: |
|
1.7 ;
2.7 ;
3.& .
:
@ " (_ , 1986 .)
;
1. & - - " # " " " , - " # " ," ;
2.& " 3- " &$# 3 " ;
3.3 " - # & " ,
% " " ", " 3 .
' & :
1."- " , 3 & & &,
" & 1 ;
2.&- - " # " ;
3. |
" – , " % , |
|
" ; |
4." – , " ;
5.3 " – " (2 ), "
(3 ) " ; "$ " .
$ :
1." – , &, % , , , ;
2.3 "- ; II, III, aVF" ;
3.3 "- "
& ( 3 ) " ; 4. - % " 3 ,
& .
" & :
1.# (6 );
2.7 ;
3.G 7 ;
4.7 , ;
5., ;
6.( );
7.3 ;
8.H)B $ ;
9./ ;
10.# " ;
11.& ;
12.& ;
13.& .
" & & :
1.!-3 ;
2.L # 3 ;
3.' 3 ;
4.H)B ;
5.% ;
6.7 3 ;
7.7 3 ;
8.7 ;
9.& ;
10.& ;
11.& ;
12.;
13.;
14., ;
15." % ;
16." & .
17.;
18.– ;
19.!- ;
20.# ;
21.;
22.;
23.3 - , ;
24.B ;
25.;
26.?J;;
27.?!;;
28..
+ :
1.!$ % , " .
2., -, % - , " - 3 - $ , 3 .
3.! " " , J- .
4."$# # , ,
|
|
( |
|
|
) |
|
, |
3 |
, |
|||||||||||
|
* 2,5-15 2-3 |
; |
250 3 / , |
* 200-400 |
||||||||||||||||
|
2 , 0,5-1,0 , 100 3 , |
|||||||||||||||||||
|
0,15-0,25 . 3 &, |
|
' |
& |
1 |
|||||||||||||||
|
. 2-3 &, * |
50-75 , |
* |
10-15 , |
||||||||||||||||
|
50-100 2 |
, 25-75 . |
|
|
|
|
|
|||||||||||||
5. |
" |
|
( |
|
) – 75-100 , |
|||||||||||||||
|
"& * 200-400-800 / / / , |
|||||||||||||||||||
|
0,4-0,8 . , 0,025 -0,05 -0,1 . / / -1 |
|||||||||||||||||||
|
&, |
10-20 / / , 3 ; |
1 -3 &; |
|||||||||||||||||
|
1-3 , " & 2 |
|
|
|||||||||||||||||
|
" |
$# |
. |
|
|
|
|
|
||||||||||||
6. |
? & |
( |
|
) – * |
0,125-0,5 3 & |
|||||||||||||||
|
10 , |
/ * 1,875 3 |
10 ; 3 * 30-50 |
|||||||||||||||||
|
/ / 4 ; * |
50-100 / / . |
|
|
|
|
|
|
|
|
||||||||||
7. |
|
% |
|
|
|
( |
) |
|
||||||||||||
|
- - - |
|
* 0,25-0,5 / / 3 |
|
||||||||||||||||
|
* 50-100 , |
% - |
|
|||||||||||||||||
|
0,2-0,3 , |
3-7 .-2 &. |
|
|
|
|
|
|
|
|
||||||||||
8. |
? " |
" |
– * 5-9 / / |
|||||||||||||||||
|
3 |
, * 1-2 / / , * 1-3 / / . 2-3 |
, |
|||||||||||||||||
* 50 / / .
9. & " " # - " : " " # ¨¨- * %$# 0,008-0,01 / / 2 " 12 " ; * 1-3 / / . 3* 2-4 / / .; ?_ – 0,3-1,5 / / 33 * 2,5-20 / 2 .
" & :
1.*@ 2 , 5 , .;
2., " & 5, 10 20 V ;
3.*@ "& 200 , V ; 40 / 10%, 20% ;
4.*? 500 , 1000 , .; 250 ; 500 , .; 250 /5 &;
5.*? / 625 , .; 600 , , V ;
6. *7 250 , 500 , .; 250 /5 & ;
7.*/ 1000 , V ;
8.* 40 , .;
9.*? 200 , .; 150 /3 , .;
10.*J , 1%, 2%, 10% ( ) 2 , 10 , V ;
11.*@ 62,5 , 250 , .; 0,025% 1 , .;
12.*_40 , .; 20 /2 , .;
13.*7 2,5 , 10 , .; 1,25 /1 , .
" & & :
1.+ , 3 30 ;
2.*' 5 , 10 , .; 2 , .;
3.50 , .;
4.*? 50 , 100 .;
5.*' 40 , 80 , .;
6.*? 1% 1 , ;
7.*! 25 , 50 .
,- ! - :
3 " :
1."- &
2.,
3.& ,
4.,
5." :
1.,
2." " ,
3.& 3 , & .
/ , &
1 " + " " : B.+.@ , M.J. K " – 6.: 7 ;?-6>@, 2004. – 1184 .: . ( «@ & 6 »)
2. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography A Report of the American College of Cardiology/American Heart Association Task Force on Practice
Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)
3.Scottish Intercollegiate Guidelines Network A National Clinical Guideline Antithrombotic Therapy March 1999
4.Management of Patients WithValvular Heart Disease A Report of the American College ACC/AHA Pocket GuidelinesA Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines July 2000
5.Mitral Valve Prolapse: Time for a Fresh Look. Reviews in Cardiovascular Medicine 2001; 2(2): 73-81. Guidelines: https://www.americanheart.org
* – , # (% % )
